159 related articles for article (PubMed ID: 36437222)
1. Prospective, Randomized, Double-blind, Placebo-controlled, Pilot Study of Extracorporeal Shock Wave Therapy for Detrusor Underactivity/Underactive Bladder.
Shen YC; Chen CH; Chancellor MB; Chuang YC
Eur Urol Focus; 2023 May; 9(3):524-530. PubMed ID: 36437222
[TBL] [Abstract][Full Text] [Related]
2. Pain reduction realized with extracorporeal shock wave therapy for the treatment of symptoms associated with interstitial cystitis/bladder pain syndrome-A prospective, multicenter, randomized, double-blind, placebo-controlled study.
Chuang YC; Meng E; Chancellor M; Kuo HC
Neurourol Urodyn; 2020 Jun; 39(5):1505-1514. PubMed ID: 32394478
[TBL] [Abstract][Full Text] [Related]
3. Low-intensity extracorporeal shockwave therapy ameliorates diabetic underactive bladder in streptozotocin-induced diabetic rats.
Wang HS; Oh BS; Wang B; Ruan Y; Zhou J; Banie L; Lee YC; Tamaddon A; Zhou T; Wang G; Lin G; Lue TF
BJU Int; 2018 Sep; 122(3):490-500. PubMed ID: 29603534
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic-3-receptor positive allosteric modulator ASP8302 in patients with underactive bladder. A randomized controlled trial.
van Till JWO; Arita E; Kuroishi K; Croy R; Oelke M; van Koeveringe GA; Chapple CR; Yamaguchi O; Abrams P
Neurourol Urodyn; 2022 Jun; 41(5):1139-1148. PubMed ID: 35419807
[TBL] [Abstract][Full Text] [Related]
5. Underactive Bladder and Detrusor Underactivity: New Advances and Prospectives.
Wang J; Ren L; Liu X; Liu J; Ling Q
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958499
[TBL] [Abstract][Full Text] [Related]
6. Do the definitions of the underactive bladder and detrusor underactivity help in managing patients: International Consultation on Incontinence Research Society (ICI-RS) Think Tank 2017?
Tarcan T; Rademakers K; Arlandis S; von Gontard A; van Koeveringe GA; Abrams P
Neurourol Urodyn; 2018 Jun; 37(S4):S60-S68. PubMed ID: 30133789
[TBL] [Abstract][Full Text] [Related]
7. Long-term functional change of cryoinjury-induced detrusor underactivity and effects of extracorporeal shock wave therapy in a rat model.
Chuang YC; Tyagi P; Luo HL; Lee WC; Wang HJ; Huang CC; Chancellor MB
Int Urol Nephrol; 2019 Apr; 51(4):617-626. PubMed ID: 30796726
[TBL] [Abstract][Full Text] [Related]
8. Re: Yuan Chi Shen, Chien Hsu Chen, Michael B. Chancellor, Yao-Chi Chuang. Prospective, Randomized, Double-blind, Placebo-controlled, Pilot Study of Extracorporeal Shock Wave Therapy for Detrusor Underactivity/Underactive Bladder. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.11.011.
Usmani A; Misra A; Pratap Singh U
Eur Urol Focus; 2023 Nov; 9(6):1077. PubMed ID: 37142536
[No Abstract] [Full Text] [Related]
9. Urodynamic and molecular characteristics of detrusor underactivity in a rat cryoinjury model and effects of low energy shock wave therapy.
Chuang YC; Tyagi P; Wang HJ; Huang CC; Lin CC; Chancellor MB
Neurourol Urodyn; 2018 Feb; 37(2):708-715. PubMed ID: 28767169
[TBL] [Abstract][Full Text] [Related]
10. Is coexistent overactive-underactive bladder (with or without detrusor overactivity and underactivity) a real clinical syndrome? ICI-RS 2019.
Mancini V; Tarcan T; Serati M; Wyndaele M; Carrieri G; Abrams P
Neurourol Urodyn; 2020 Jul; 39 Suppl 3():S50-S59. PubMed ID: 32032454
[TBL] [Abstract][Full Text] [Related]
11. Detrusor underactivity in pelvic organ prolapse.
Frigerio M; Manodoro S; Cola A; Palmieri S; Spelzini F; Milani R
Int Urogynecol J; 2018 Aug; 29(8):1111-1116. PubMed ID: 29270721
[TBL] [Abstract][Full Text] [Related]
12. Current pharmacological and surgical treatment of underactive bladder.
Jiang YH; Lee CL; Jhang JF; Kuo HC
Ci Ji Yi Xue Za Zhi; 2017; 29(4):187-191. PubMed ID: 29296045
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of Low intensity Extracorporeal Shock Wave Therapy (Li-ESWT) on diabetic bladder dysfunction in a rat model.
Lee YC; Hsieh TJ; Tang FH; Jhan JH; Lin KL; Juan YS; Wang HS; Long CY
Int J Med Sci; 2021; 18(6):1423-1431. PubMed ID: 33628099
[No Abstract] [Full Text] [Related]
14. EP2 and EP3 receptors as therapeutic targets for underactive bladder/detrusor underactivity due to diabetic cystopathy in a type 1 diabetic rat model.
Sekido N; Otsuki T; Kida J; Mashimo H; Wakamatsu D; Okada H; Matsuya H
Low Urin Tract Symptoms; 2020 Sep; 12(3):285-291. PubMed ID: 32410343
[TBL] [Abstract][Full Text] [Related]
15. Clinical diagnostic criteria for detrusor underactivity: A report from the Japanese Continence Society working group on underactive bladder.
Yoshida M; Sekido N; Matsukawa Y; Yono M; Yamaguchi O
Low Urin Tract Symptoms; 2021 Jan; 13(1):13-16. PubMed ID: 33029933
[TBL] [Abstract][Full Text] [Related]
16. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis.
Osman NI; Chapple CR; Abrams P; Dmochowski R; Haab F; Nitti V; Koelbl H; van Kerrebroeck P; Wein AJ
Eur Urol; 2014 Feb; 65(2):389-98. PubMed ID: 24184024
[TBL] [Abstract][Full Text] [Related]
17. Qualitative Exploration of the Patient Experience of Underactive Bladder.
Uren AD; Cotterill N; Harding C; Hillary C; Chapple C; Klaver M; Bongaerts D; Hakimi Z; Abrams P
Eur Urol; 2017 Sep; 72(3):402-407. PubMed ID: 28400168
[TBL] [Abstract][Full Text] [Related]
18. Definition and symptoms of underactive bladder.
Uren AD; Drake MJ
Investig Clin Urol; 2017 Dec; 58(Suppl 2):S61-S67. PubMed ID: 29279877
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of TAC-302 for patients with detrusor underactivity and overactive bladder: a randomized, double-blind, placebo-controlled phase 2 study.
Yoshida M; Gotoh M; Yokoyama O; Kakizaki H; Yamanishi T; Yamaguchi O
World J Urol; 2022 Nov; 40(11):2799-2805. PubMed ID: 36205739
[TBL] [Abstract][Full Text] [Related]
20. Detrusor Underactivity and the Underactive Bladder: A Systematic Review of Preclinical and Clinical Studies.
Osman NI; Esperto F; Chapple CR
Eur Urol; 2018 Nov; 74(5):633-643. PubMed ID: 30139634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
